Food Effect of VS-6766 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 16, 2021

Primary Completion Date

April 12, 2022

Study Completion Date

April 12, 2022

Conditions

Food Effect

Interventions

DRUG

VS-6766

Dual RAF/MEK inhibitor

Trial Locations (1)

Celerion, Tempe

All Listed Sponsors

lead

Verastem, Inc.

INDUSTRY

NCT05187169 - Food Effect of VS-6766 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter